You searched for metabolic diseases - Page 40 of 64

Podcast 12 Jan 2024

Could natural killer cells transform Alzheimer’s treatment?

…various diseases, whether it be autoimmune diseases or cancer susceptibility, is there a therapy for that?” Song said. So, the company set about developing a natural killer cell therapy to…

January 12, 2024 - 6 minutesmins - By Jim Cornall

News and Trends 6 Jan 2023

BioNTech partnering with UK Government on personalized mRNA cancer immunotherapies

…diseases affecting collectively hundreds of millions of people worldwide. If successful, this collaboration has the potential to improve outcomes for patients and provide early access to our suite of cancer…

January 6, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 13 Mar 2017

This Dutch Company is Upgrading ADCs for Immunotherapy

…Xenikos, in 2009 to further refine T-Guard as a treatment for acute graft-versus-host disease (GVHD) and other orphan diseases. We talked to him about his technology and company outlook. What…

March 13, 2017 - 7 minutesmins - By External Contributor

News and Trends 23 Jul 2018

Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease

…focussed biotechs are combating cancer, TxCell is going one step further by developing CAR-T therapies for autoimmune diseases using a different type of CAR-T cell. Usually, CAR-T therapies use killer…

July 23, 2018 - 3 minutesmins - By Alexander Burik

liver anatomy organs Sebastian Kaulitzki fi

News and Trends 21 Nov 2016

“We are Pioneering Cell Therapy to Cure NASH and Fibrotic Disease”

…Regarding R&D, our territory is expanding from rare diseases to immune modulation using our mesenchymal stem cells (MSC’s). Our MSC’s are called HepaStem, which were originally used for UCD for…

November 21, 2016 - 7 minutesmins - By Evelyn Warner

News and Trends 24 Jan 2023

Ubiquigent and University of Glasgow to collaborate on drug discovery

…University of Glasgow (UoG) to undertake a research project on USP30, a DUB implicated in neruodegenerative, renal, and cardiovascular diseases. Overseen by structural biology experts Helen Walden, UoG, and Mehmet…

January 24, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 21 Apr 2023

RetinAI and Boehringer Ingelheim to use AI to develop treatment for geographic atrophy

…patient outcomes in geographic atrophy (GA) by combining RetinAI’s Discovery platform and AI tools with Boehringer Ingelheim’s research in retinal diseases. GA is a progressive, advanced form of age-related macular…

April 21, 2023 - 2 minutesmins - By Jim Cornall

Interview 31 Aug 2022

How CDMOs keep pace with trends in advanced therapies

…for protein-based therapeutics. The intracellular mode of action is expected to allow the treatment of diseases that so far could not be tackled, such as genetic diseases where patients lack…

August 31, 2022 - 8 minutesmins - By Jonathan Smith

signing contract PORTRAIT IMAGES ASIA BY NONWARIT fi

News and Trends 17 Oct 2016

TxCell lines up another duck in its CAR-Treg campaign

Novartis veteran Li Zhou has joined TxCell as the VP of cell engineering to oversee CAR-Treg programs for autoimmune and inflammation diseases. The French Treg maverick, TxCell, has hoovered up…

October 17, 2016 - 2 minutesmins - By Evelyn Warner

Interview 19 Feb 2018

Taking CAR-T Cells Beyond Cancer: A New Therapy for Autoimmune Disease

…powerful, very directed, very targeted kind of therapy. Again, we have to be cautious, but if it works, there is a very large panel of diseases we can potentially target….

February 19, 2018 - 9 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 5 Jul 2023

Six biotech companies leading the way in Hong Kong

…certain proteins for the diagnosis of various diseases. Another technology that the biotech focuses on is the BioChip. The BioChip is able to detect a number of respiratory-disease causing pathogens…

July 5, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 2 Nov 2017

German Biotech Pockets €18M in its Series A to Propel Autoimmune Disease Candidate Forward

…autoimmune diseases with high medical need. With the announcement of a €18M Series A, it hopes to take begin moving its candidates into the clinic. It had raised €14M thanks…

November 2, 2017 - 2 minutesmins - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Could natural killer cells transform Alzheimer’s treatment?

BioNTech partnering with UK Government on personalized mRNA cancer immunotherapies

This Dutch Company is Upgrading ADCs for Immunotherapy

Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease

“We are Pioneering Cell Therapy to Cure NASH and Fibrotic Disease”

Ubiquigent and University of Glasgow to collaborate on drug discovery

RetinAI and Boehringer Ingelheim to use AI to develop treatment for geographic atrophy

How CDMOs keep pace with trends in advanced therapies

TxCell lines up another duck in its CAR-Treg campaign

Taking CAR-T Cells Beyond Cancer: A New Therapy for Autoimmune Disease

Six biotech companies leading the way in Hong Kong

German Biotech Pockets €18M in its Series A to Propel Autoimmune Disease Candidate Forward

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!